Green Leaf Pharma (02186.HK) released its interim financial results, with a net profit attributable to shareholders of 313 million yuan, a decrease of 19.33% year-on-year.

Zhixin Finance APP News, Leaf Pharmaceuticals (02186.HK) released its interim results for the 6 months ending June 30, 2025. The group achieved revenue of RMB 3.181 billion (all in the same unit), an increase of 3.46% year-on-year; the attributable profit to the parent company's owner was RMB 313 million, a decrease of 19.33% year-on-year; earnings per share were 8.32 cents.